Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
9 Leser
Artikel bewerten:
(0)

Unilens Announces Change in Jurisdiction From British Columbia Canada to the State of Delaware

LARGO, Fla., April 1 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF, UVIC; TSX Venture Exchange: UVI) announced the change in domicile and the continuance of its Corporate existence from British Columbia Canada to the State of Delaware effective today. The continuation to Delaware, which was overwhelmingly approved by shareholders on March 25, 2010, does not result in any change in the business, assets, liabilities, net worth, or management of the Company.

"We are pleased that as an SEC registered Delaware corporation, our corporate governance will now be a matter of U.S. law, eliminating in some cases redundant and conflicting requirements between U.S. and Canadian jurisdictions," stated Michael Pecora, Chief Executive Officer of Unilens Vision Inc. "Furthermore, we believe that trading as a U.S. issuer on the OTC Bulletin Board, rather than as a foreign private issuer may result in greater potential interest by investors, resulting in a more active market for our shares," concluded Mr. Pecora.

The Company's shares will continue to trade on the OTC Bulletin Board, utilizing the 4-digit symbol "UVIC" and on the TSX Venture exchange under the symbol "UVI".

About Unilens Vision Inc. - "The Independent Eye Care Professionals Contact Lens Company"

Established in 1989, Unilens Vision Inc., a Delaware corporation, through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-Vue brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at http://www.unilens.com/. The Company's common stock is listed on the OTC Bulletin Board under the symbol "UVIC" as well as the Canadian TSX Venture Exchange under the symbol "UVI".

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

For more information, please contact:

Leonard F. Barker at (727) 544-2531

Unilens Vision Inc.

CONTACT: Leonard F. Barker, +1-727-544-2531

Web Site: http://www.unilens.com/

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2010 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.